Sunday 18 November 2018
Home      All news      Contact us      Philipino
Channel News Asia - 28 days ago

AstraZeneca s Lynparza shown to put brakes on ovarian cancer

An AstraZeneca drug that blocks a cancer cell s ability to repair its genetic code greatly reduced the risk of ovarian cancer worsening in a phase III trial, underpinning its lead against two U.S. rivals in the same class.

Related news

Latest News
Hashtags:   

AstraZeneca

 | 

Lynparza

 | 

shown

 | 

brakes

 | 

ovarian

 | 

cancer

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources